Kraig Biocraft Laboratories, Inc. (KBLB)

KBLB Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	2.89	1.79	0.67	2.55	3.86	2.36
Short-Term Investments	-	-	-	-	0.1	-
Cash & Short-Term Investments	2.89	1.79	0.67	2.55	3.96	2.36
Cash Growth	628.21%	165.90%	-73.62%	-35.58%	68.20%	188.29%
Inventory	0.07	0.03	0.01	0.01	0.01	-
Prepaid Expenses	0.05	0.05	0.06	0.01	0.02	0.01
Total Current Assets	3.01	1.87	0.74	2.57	3.98	2.37
Property, Plant & Equipment	0.19	0.2	0.13	0.16	0.15	0.22
Long-Term Investments	0.51	0.49	0.63	0.49	0.44	0.44
Other Long-Term Assets	0.01	0.01	0.01	0	0	0
Total Assets	3.72	2.57	1.51	3.23	4.57	3.02

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	0.83	0.81	0.8	0.93	0.9	0.59
Accrued Expenses	8.31	8.09	7.15	6.26	5.42	4.96
Short-Term Debt	1.49	1.49	1.62	1.65	1.71	2.16
Current Portion of Long-Term Debt	-	-	-	-	-	0.06
Current Portion of Leases	0.05	0.05	0.05	0.04	0.04	0.04
Other Current Liabilities	-	-	-	-	-	0.35
Total Current Liabilities	10.68	10.45	9.61	8.89	8.07	8.16
Long-Term Debt	-	-	-	-	-	0.1
Long-Term Leases	0.11	0.12	0.04	0.05	0.02	0.06
Total Liabilities	10.78	10.56	9.65	8.94	8.09	8.32

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	32.66	31.02	27.39	27.39	27.08	22.39
Additional Paid-In Capital	12.67	12.43	12.29	11.35	10.83	9.89
Retained Earnings	-57.65	-56.71	-53.09	-49.69	-46.66	-42.81
Comprehensive Income & Other	0.02	0.02	0.02	0.02	-	0.02
Total Common Equity	-12.3	-13.24	-13.39	-10.92	-8.74	-10.51
Shareholders' Equity	-7.06	-8	-8.15	-5.71	-3.52	-5.3
Total Liabilities & Equity	3.72	2.57	1.51	3.23	4.57	3.02

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	1.65	1.66	1.7	1.75	1.77	2.42
Net Cash (Debt)	1.24	0.13	-1.03	0.8	2.19	-0.07
Net Cash Growth	-	-	-	-63.30%	-	-
Net Cash Per Share	0.00	0.00	-0.00	0.00	0.00	-0.00
Filing Date Shares Outstanding	1,113	1,100	1,043	1,038	1,033	950.91
Total Common Shares Outstanding	1,101	1,084	1,038	1,038	1,031	927.38
Working Capital	-7.67	-8.58	-8.87	-6.31	-4.09	-5.8
Book Value Per Share	-0.01	-0.01	-0.01	-0.01	-0.01	-0.01
Tangible Book Value	-12.3	-13.24	-13.39	-10.92	-8.74	-10.51
Tangible Book Value Per Share	-0.01	-0.01	-0.01	-0.01	-0.01	-0.01
Machinery	0.2	0.19	0.18	0.18	0.17	0.17
Leasehold Improvements	0.08	0.08	0.08	0.08	0.08	0.08

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 26, 2026

Data Sources Report a data error